Call for Abstract
Scientific Program
7th International Conference on Drug Discovery and Toxicology, will be organized around the theme “New Era Technologies in Drug Formulation & Novelties in Toxicology”
Drug Discovery Congress 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Drug Discovery Congress 2020
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Traditional medicines and herbal therapy
- Track 1-2Natural products in drug discovery
- Track 1-3Lead identification and validation
- Track 1-4Quantitative structure activity relationship
- Track 1-5Development challenges
- Track 2-1Management of equipment
- Track 2-2Importance of species selection
- Track 2-3Ethical issues
- Track 2-4Phases in clinical trails
- Track 3-1Nanomedicine
- Track 3-2Pharmaceutical Nanotechnology
- Track 3-3Nano drugs, Nanomaterial & Biopharmaceuticals
- Track 3-4Dendrimers
- Track 3-5Polymeric and ceramic nano particles
- Track 3-6Development of nanoemulsions
- Track 3-7Micelles for drug targeting
- Track 3-8Nano-biotechnology in drug discovery
- Track 4-1Electrospray Ionization Mass Spectroscopy.
- Track 4-2Hydrophobic Interaction chromatography.
- Track 4-3Paper Chromatography Hybridization Assay (PACHA)
- Track 4-4Convergence Chromatography.
- Track 4-5High-performance and Immuno-affinity chromatography.
- Track 4-6Optical force chromatography.
- Track 5-1Personalized medication
- Track 5-2Revive orphan drug
- Track 5-3 Target identification in drug discovery
- Track 6-1Generation of Chemical Structures
- Track 6-2Multiscale Molecular Structure
- Track 6-3Molecular Docking
- Track 6-4Pharmachophore modelling
- Track 7-1Good manufacturing practice (GMP)
- Track 7-2Product safety testing
- Track 7-3Quality control in production process
- Track 7-4Pharmaceutical drug validation
- Track 8-1Mechanism of action of drugs
- Track 8-2Molecular imaging of drug
- Track 8-3Monitoring patient health
- Track 8-4Diagnosis of disease condition
- Track 9-1Drug delivery system
- Track 9-2Microencapsulation
- Track 9-3Nasal and Pulmonary routes of administration
- Track 9-4Novel drug targets
- Track 10-1Clinical and medicinal toxicology
- Track 10-2Forensic toxicology
- Track 10-3Food and nutritional toxicology
- Track 10-4Analytical toxicology
- Track 10-5Environmental toxicology
- Track 11-1Hepato and renal toxicology
- Track 11-2Reproductive and developmental toxicology
- Track 11-3Immunotoxicology
- Track 11-4Metal toxicology
- Track 11-5Bone marrow toxicity
- Track 11-6Neurotoxicology
- Track 11-7Nanoparticle toxicology
- Track 12-1Identify toxic hazards
- Track 12-2Dose response evaluation
- Track 12-3Exposure assessment
- Track 12-4Risk characterization
- Track 13-1Structure and ligand based drug design
- Track 13-2Protein Binding site identification
- Track 13-3Lead optimization in drug metabolism
- Track 14-1Monitoring techniques
- Track 14-2Regulatory affairs
- Track 14-3Pharmacovilance
- Track 14-4Drug regulation
- Track 15-1Targeting RNA with small molecules
- Track 15-2Role of artificial intelligence in drug discovery
- Track 15-3Bioprinting
- Track 15-4Human organs-on-a-chip
- Track 16-1Topical Cream-Based Dosage Forms
- Track 16-2Developments in injectable drug delivery
- Track 16-3new oral drug delivery -mouth dissolving formulation
- Track 16-4Design and formulation of capsules
- Track 16-5Targeted delivery of respiratory vaccines
- Track 17-1Beginning of mass production
- Track 17-2Biomaterials and Biomechanics
- Track 17-3Automation in Pharmaceutical Manufacturing
- Track 18-1Pharmacokinetics in relative bioavalibility
- Track 18-2 Absolute oral bioavailability and disposition kinetics
- Track 18-3Theoretical Analysis of Drug Dissolution
- Track 18-4Various Approaches to Enhance Drug Solubility
- Track 19-1Design for a safer dispensing process
- Track 19-2 Microelectronics and electronic packaging
- Track 19-3Automated Packaging Machine
- Track 20-1Phenotypic drug discovery
- Track 20-2High throughput screening by mass spectroscopy
- Track 20-3Current trends in label free technologies
- Track 20-4Next generation sequencing technologies
